Multiple Sclerosis MS

02:26 EST 13th December 2018 | BioPortfolio

Multiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK.

The condition results from autoimmune damage to myelin, causing interference in nerve signaling. Symptoms experienced depend on the part of the nervous system that is affected. MS can have a progressive pattern, or can have periods of relapse and remission. 

There is little evidence for a genetic link with MS, but environmental factors may be important; MS is more common in areas further away from the equator, suggesting Vitamin D or a virus may be linked.

There is no cure for MS, but there is a lot of active research in the field.

Source; Adapted from the MS Society (UK)

Follow and track Multiple sclerosis News on BioPortfolio:

Follow and track Multiple sclerosis News on RSS
Follow and track Multiple sclerosis News on Twitter



Quick Search


review and buy Multiple Sclerosis MS market research data and corporate reports here